SPDR S&P Biotech ETF (NYSEARCA:XBI) Hits New 12-Month High – What’s Next?

SPDR S&P Biotech ETF (NYSEARCA:XBI) shares hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $167.15 and last traded at $166.85, with a volume of 2785309 shares changing hands. The stock had previously closed at $160.11.

SPDR S&P Biotech ETF Price Performance

The stock has a market cap of $10.94 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. The stock’s 50-day moving average is $151.93 and its 200-day moving average is $136.92.

Hedge Funds Weigh In On SPDR S&P Biotech ETF

Institutional investors have recently added to or reduced their stakes in the business. Compound Planning Inc. raised its holdings in SPDR S&P Biotech ETF by 0.7% during the 1st quarter. Compound Planning Inc. now owns 10,889 shares of the exchange traded fund’s stock valued at $1,391,000 after buying an additional 75 shares during the last quarter. Dynamic Wealth Strategies LLC grew its holdings in SPDR S&P Biotech ETF by 3.8% in the 4th quarter. Dynamic Wealth Strategies LLC now owns 2,201 shares of the exchange traded fund’s stock worth $268,000 after acquiring an additional 80 shares during the last quarter. PeakShares LLC increased its position in shares of SPDR S&P Biotech ETF by 5.2% in the first quarter. PeakShares LLC now owns 1,684 shares of the exchange traded fund’s stock valued at $215,000 after acquiring an additional 84 shares during the period. Commerce Bank increased its position in shares of SPDR S&P Biotech ETF by 2.8% in the fourth quarter. Commerce Bank now owns 3,260 shares of the exchange traded fund’s stock valued at $397,000 after acquiring an additional 90 shares during the period. Finally, Compass Ion Advisors LLC increased its position in shares of SPDR S&P Biotech ETF by 2.6% in the fourth quarter. Compass Ion Advisors LLC now owns 3,886 shares of the exchange traded fund’s stock valued at $474,000 after acquiring an additional 97 shares during the period.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.